Sang-Heon Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sang-Heon Cho has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Cheol-Woo Kim
Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea
2 shared publications Hyun-Jung Kwon
Department of Clinical Pharmacology, Inha University Hospital, Inha University School of Medicine, Incheon, the Republic of Korea
2 shared publications- Moonsuk Nam
Department of Internal Medicine, Inha University School of Medicine, Incheon, Korea.
2 shared publications - Bo-Hyung Kim
Department of Clinical Pharmacology and Therapeutics, Kyung Hee University College of Medicine, Kyung Hee University Hospital
1 shared publication Cheol-Woo Kim
Department of Clinical Pharmacology, Inha University Hospital, Inha University School of Medicine, Incheon 22332, South Korea
1 shared publication- Dae-Young Kim
Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 11 March 2026
- Published by Korean Society of Occupational & Environmental Medicine in Annals of Occupational and Environmental Medicine
- Vol. 38, e8
Severe bilateral hydrocarbon pneumonitis requiring surgical drainage following accidental aspiration of industrial cleaning solvent in a seafarer: a case report
Background: Hydrocarbon pneumonitis is typically self-limiting, and severe complications, such as lung abscesses, are rare. Here, we report the case of a seafarer who developed bilateral lung abscesses after aspirating an industrial cleaning solvent, highlighting the aggravating role of delayed medical care and improper first-aid measures in a maritime setting.Case presentation: A 46-year-old seafarer presented with dyspnea, 3 days after accidentally ingesting a hydrocarbon-based solvent that he mistook for water. Although he immediately spat out the fluid, he aspirated a small amount. His condition rapidly deteriorated to necrotizing pneumonia with bilateral lung abscesses, as confirmed by chest computed tomography. Despite empirical antibiotic therapy, the abscess worsened, necessitating a video-assisted thoracic surgery for drainage. The patient recovered after surgery and underwent a prolonged course of antibiotic therapy. Conclusions: This case underscores the potential for life-threatening complications from industrial solvent aspiration, exacerbated by delayed medical care and forceful spitting. Strict workplace safety protocols, including the prohibition of storing chemicals in food containers to avoid confusion, and awareness about not inducing vomiting after ingestion, are essential to prevent such severe occupational injuries.
- 11 March 2026
- Published by Korean Society of Occupational & Environmental Medicine in Annals of Occupational and Environmental Medicine
- Vol. 38, e8
Open AccessSevere bilateral hydrocarbon pneumonitis requiring surgical drainage following accidental aspiration of industrial cleaning solvent in a seafarer: a case report
Background: Hydrocarbon pneumonitis is typically self-limiting, and severe complications, such as lung abscesses, are rare. Here, we report the case of a seafarer who developed bilateral lung abscesses after aspirating an industrial cleaning solvent, highlighting the aggravating role of delayed medical care and improper first-aid measures in a maritime setting.Case presentation: A 46-year-old seafarer presented with dyspnea, 3 days after accidentally ingesting a hydrocarbon-based solvent that he mistook for water. Although he immediately spat out the fluid, he aspirated a small amount. His condition rapidly deteriorated to necrotizing pneumonia with bilateral lung abscesses, as confirmed by chest computed tomography. Despite empirical antibiotic therapy, the abscess worsened, necessitating a video-assisted thoracic surgery for drainage. The patient recovered after surgery and underwent a prolonged course of antibiotic therapy. Conclusions: This case underscores the potential for life-threatening complications from industrial solvent aspiration, exacerbated by delayed medical care and forceful spitting. Strict workplace safety protocols, including the prohibition of storing chemicals in food containers to avoid confusion, and awareness about not inducing vomiting after ingestion, are essential to prevent such severe occupational injuries.
- 19 September 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115734
Simple and robust LC–MS/MS method for quantification of colistin methanesulfonate and colistin in human plasma for therapeutic drug monitoring
- 19 September 2023
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 236, 115734
Simple and robust LC–MS/MS method for quantification of colistin methanesulfonate and colistin in human plasma for therapeutic drug monitoring
- Open Access
- 16 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (37) , e30527
Association between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
While patients with nonalcoholic fatty liver disease (NAFLD) continue to increase worldwide, few hematological biomarkers are helpful. This study examined the potential of small dense low density lipoprotein (sdLDL) as a noninvasive biomarker for NAFLD and investigated the relevance of liver fibrosis. One hundred seventy two patients were enrolled: 121 NAFLD patients and 51 healthy controls. The lipoprotein profiles of NAFLD patients and controls were analyzed, and transient elastography (Fibroscan®) was performed to evaluate the degree of NAFLD. The liver biopsy results in some NAFLD patients were also analyzed. Age-gender matching was performed among the 172 patients, and a comparison with 46 NAFLD patients with the control group confirmed that the sdLDL (P < .001) is significantly higher in the NAFLD group. A liver fibrosis test performed on 121 NAFLD patients confirmed a positive correlation between the degree of hepatic fibrosis and the sdLDL/LDL ratio (R = 0.215, P = .017). The area under the curve of the sdLDL for the diagnosis of NAFLD was 0.734 (95% CI, 0.631–0.838), and the area under the curve of the sdLDL/LDL ratio was 0.730 (95% CI, 0.621–0.829). The sdLDL and NAFLD activity scores of the 11 NAFLD patients who underwent liver biopsy showed a positive correlation, but it was not statistically significant. The sdLDL was higher in NAFLD patients than in controls and showed a tendency to increase gradually with increasing degree of hepatic steatosis and fibrosis. In particular, the sdLDL/LDL ratio showed a significant correlation with the degree of hepatic fibrosis, and the sdLDL measurement could be useful in NAFLD patients.
- 16 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (37) , e30527
Open AccessAssociation between small dense LDL levels and hepatic fibrosis in patients with nonalcoholic fatty liver disease
While patients with nonalcoholic fatty liver disease (NAFLD) continue to increase worldwide, few hematological biomarkers are helpful. This study examined the potential of small dense low density lipoprotein (sdLDL) as a noninvasive biomarker for NAFLD and investigated the relevance of liver fibrosis. One hundred seventy two patients were enrolled: 121 NAFLD patients and 51 healthy controls. The lipoprotein profiles of NAFLD patients and controls were analyzed, and transient elastography (Fibroscan®) was performed to evaluate the degree of NAFLD. The liver biopsy results in some NAFLD patients were also analyzed. Age-gender matching was performed among the 172 patients, and a comparison with 46 NAFLD patients with the control group confirmed that the sdLDL (P < .001) is significantly higher in the NAFLD group. A liver fibrosis test performed on 121 NAFLD patients confirmed a positive correlation between the degree of hepatic fibrosis and the sdLDL/LDL ratio (R = 0.215, P = .017). The area under the curve of the sdLDL for the diagnosis of NAFLD was 0.734 (95% CI, 0.631–0.838), and the area under the curve of the sdLDL/LDL ratio was 0.730 (95% CI, 0.621–0.829). The sdLDL and NAFLD activity scores of the 11 NAFLD patients who underwent liver biopsy showed a positive correlation, but it was not statistically significant. The sdLDL was higher in NAFLD patients than in controls and showed a tendency to increase gradually with increasing degree of hepatic steatosis and fibrosis. In particular, the sdLDL/LDL ratio showed a significant correlation with the degree of hepatic fibrosis, and the sdLDL measurement could be useful in NAFLD patients.
- Open Access
- 1 January 2020
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 52 (2) , 204-211
Pharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
Cho SH, et al. Infect Chemother. 2020 Jun;52(2):204-211. https://doi.org/10.3947/ic.2020.52.2.204
- 1 January 2020
- Published by Korean Society of Infectious Diseases and Korean Society for Chemotherapy in Infection & Chemotherapy
- Vol. 52 (2) , 204-211
Open AccessPharmacokinetics and Safety of Two Voriconazole Formulations after Intravenous Infusion in Healthy Korean Volunteers
Cho SH, et al. Infect Chemother. 2020 Jun;52(2):204-211. https://doi.org/10.3947/ic.2020.52.2.204
- 9 March 2019
- Published by Springer Nature in BioDrugs
- Vol. 33 (2) , 173-181
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
CT-P16 is a candidate biosimilar of bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor that is used in the treatment of a range of advanced solid cancers.
- 9 March 2019
- Published by Springer Nature in BioDrugs
- Vol. 33 (2) , 173-181
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
CT-P16 is a candidate biosimilar of bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor that is used in the treatment of a range of advanced solid cancers.
- Open Access
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (33) , e218
Oral Allergy Syndrome in Birch Pollen-Sensitized Patients from a Korean University Hospital
Kim JH, et al. J Korean Med Sci. 2018 Jun;33(33):e218. https://doi.org/10.3346/jkms.2018.33.e218
- 1 January 2018
- Published by XMLink in Journal of Korean Medical Science
- Vol. 33 (33) , e218
Open AccessOral Allergy Syndrome in Birch Pollen-Sensitized Patients from a Korean University Hospital
Kim JH, et al. J Korean Med Sci. 2018 Jun;33(33):e218. https://doi.org/10.3346/jkms.2018.33.e218
- Open Access
- 1 January 2017
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 25 (1) , 21-27
Validated UPLC-MS/MS method for the determination of tadalafil in human plasma and its application to a pharmacokinetic study
Kim KY, et al. Transl Clin Pharmacol. 2017 Mar;25(1):21-27. https://doi.org/10.12793/tcp.2017.25.1.21
- 1 January 2017
- Published by XMLink in Translational and Clinical Pharmacology
- Vol. 25 (1) , 21-27
Open AccessValidated UPLC-MS/MS method for the determination of tadalafil in human plasma and its application to a pharmacokinetic study
Kim KY, et al. Transl Clin Pharmacol. 2017 Mar;25(1):21-27. https://doi.org/10.12793/tcp.2017.25.1.21
- Open Access
- 1 January 2016
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 20 (3) , 245-251
Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
Cho SH, et al. Korean J Physiol Pharmacol. 2016 May;20(3):245-251. http://dx.doi.org/10.4196/kjpp.2016.20.3.245
- 1 January 2016
- Published by The Korean Physiological Society and The Korean Society of Pharmacology in The Korean Journal of Physiology & Pharmacology
- Vol. 20 (3) , 245-251
Open AccessProspective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
Cho SH, et al. Korean J Physiol Pharmacol. 2016 May;20(3):245-251. http://dx.doi.org/10.4196/kjpp.2016.20.3.245